Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy
Background: Glioma, notably glioblastoma multiforme, is characterized by extensive inter-and intra-tumoral heterogeneity. Surprisingly, the potential for differentiation of glioma cells has not been systematically analyzed and included in patient stratification methods. In the current study, retinoi...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Glioma |
Subjects: | |
Online Access: | http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=2;spage=66;epage=78;aulast=Dreyfus |
_version_ | 1818276303729590272 |
---|---|
author | Matthieu Dreyfus Michèle El-Atifi Magali Court Marie Bidart Charles Coutton Céline Leclech Bruno Ballester Emmanuel Garcion Ali Bouamrani François Berger Didier Wion |
author_facet | Matthieu Dreyfus Michèle El-Atifi Magali Court Marie Bidart Charles Coutton Céline Leclech Bruno Ballester Emmanuel Garcion Ali Bouamrani François Berger Didier Wion |
author_sort | Matthieu Dreyfus |
collection | DOAJ |
description | Background: Glioma, notably glioblastoma multiforme, is characterized by extensive inter-and intra-tumoral heterogeneity. Surprisingly, the potential for differentiation of glioma cells has not been systematically analyzed and included in patient stratification methods. In the current study, retinoic acid (RA), a neuronal differentiation agent, was assessed for the pro-differentiative and anti-proliferative effects on glioma cells. Methods: Using RA-responsive glioma culture as an experimental paradigm, we analyzed the differentiation process both by videomicroscopy and at the mRNA (RNA-seq and reverse transcription-quantitative-polymerase chain reaction) and proteomic levels. Results: Glioma cells can differentiate into neurons in response to RA by (i) extending ultra-long cytoplasmic extensions, (ii) using these extensions to move from cell to cell either by perikaryal translocation or in a "spider-flight" like process, (iii) slowing their cell cycling, (iv) acquiring several neuronal differentiation markers such as MAPT, GAP43, DCX, NRCAM, NeuroD2, NeuroG2, and NeuN, and (v) decreasing the expression of several genes associated with glioma aggressiveness. Conclusion: These results indicate the existence of a subgroup of patients harboring RA-responsive glioma cells amenable to differentiation therapy, and stratifying such patients with a functional test is easily achievable. This provides the first step to reassess the potential of RA in the context of personalized medicine. |
first_indexed | 2024-12-12T22:43:30Z |
format | Article |
id | doaj.art-871babea5fc9484b8065741c9b662b64 |
institution | Directory Open Access Journal |
issn | 2589-6113 2589-6121 |
language | English |
last_indexed | 2024-12-12T22:43:30Z |
publishDate | 2018-01-01 |
publisher | Wolters Kluwer Medknow Publications |
record_format | Article |
series | Glioma |
spelling | doaj.art-871babea5fc9484b8065741c9b662b642022-12-22T00:09:16ZengWolters Kluwer Medknow PublicationsGlioma2589-61132589-61212018-01-0112667810.4103/glioma.glioma_3_18Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapyMatthieu DreyfusMichèle El-AtifiMagali CourtMarie BidartCharles CouttonCéline LeclechBruno BallesterEmmanuel GarcionAli BouamraniFrançois BergerDidier WionBackground: Glioma, notably glioblastoma multiforme, is characterized by extensive inter-and intra-tumoral heterogeneity. Surprisingly, the potential for differentiation of glioma cells has not been systematically analyzed and included in patient stratification methods. In the current study, retinoic acid (RA), a neuronal differentiation agent, was assessed for the pro-differentiative and anti-proliferative effects on glioma cells. Methods: Using RA-responsive glioma culture as an experimental paradigm, we analyzed the differentiation process both by videomicroscopy and at the mRNA (RNA-seq and reverse transcription-quantitative-polymerase chain reaction) and proteomic levels. Results: Glioma cells can differentiate into neurons in response to RA by (i) extending ultra-long cytoplasmic extensions, (ii) using these extensions to move from cell to cell either by perikaryal translocation or in a "spider-flight" like process, (iii) slowing their cell cycling, (iv) acquiring several neuronal differentiation markers such as MAPT, GAP43, DCX, NRCAM, NeuroD2, NeuroG2, and NeuN, and (v) decreasing the expression of several genes associated with glioma aggressiveness. Conclusion: These results indicate the existence of a subgroup of patients harboring RA-responsive glioma cells amenable to differentiation therapy, and stratifying such patients with a functional test is easily achievable. This provides the first step to reassess the potential of RA in the context of personalized medicine.http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=2;spage=66;epage=78;aulast=DreyfusDifferentiation therapygliomapersonalized medicineretinoic acid |
spellingShingle | Matthieu Dreyfus Michèle El-Atifi Magali Court Marie Bidart Charles Coutton Céline Leclech Bruno Ballester Emmanuel Garcion Ali Bouamrani François Berger Didier Wion Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy Glioma Differentiation therapy glioma personalized medicine retinoic acid |
title | Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy |
title_full | Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy |
title_fullStr | Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy |
title_full_unstemmed | Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy |
title_short | Reprogramming glioma cell cultures with retinoic acid: Additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy |
title_sort | reprogramming glioma cell cultures with retinoic acid additional arguments for reappraising the potential of retinoic acid in the context of personalized glioma therapy |
topic | Differentiation therapy glioma personalized medicine retinoic acid |
url | http://www.jglioma.com/article.asp?issn=2589-6113;year=2018;volume=1;issue=2;spage=66;epage=78;aulast=Dreyfus |
work_keys_str_mv | AT matthieudreyfus reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT micheleelatifi reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT magalicourt reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT mariebidart reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT charlescoutton reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT celineleclech reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT brunoballester reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT emmanuelgarcion reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT alibouamrani reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT francoisberger reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy AT didierwion reprogramminggliomacellcultureswithretinoicacidadditionalargumentsforreappraisingthepotentialofretinoicacidinthecontextofpersonalizedgliomatherapy |